INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -60.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -50.0% | 250 | -50.0% | 0.00% | -75.0% |
| Q1 2022 | $4,000 | -63.6% | 500 | -54.5% | 0.00% | -33.3% |
| Q4 2021 | $11,000 | -26.7% | 1,100 | +37.5% | 0.01% | -14.3% |
| Q3 2021 | $15,000 | +200.0% | 800 | +166.7% | 0.01% | +250.0% |
| Q2 2021 | $5,000 | -93.2% | 300 | -95.2% | 0.00% | -92.6% |
| Q1 2021 | $73,000 | -2.7% | 6,200 | +40.9% | 0.03% | +35.0% |
| Q4 2020 | $75,000 | +102.7% | 4,400 | +22.2% | 0.02% | +25.0% |
| Q3 2020 | $37,000 | +640.0% | 3,600 | +260.0% | 0.02% | +433.3% |
| Q2 2020 | $5,000 | +400.0% | 1,000 | +400.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
| Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
| Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
| YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
| Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
| Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
| FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
| Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
| Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |